Crossmark

Evidence supporting regulatory-decision making on orphan medicinal products authorisation in Europe: methodological uncertainties

Crossref DOI link: https://doi.org/10.1186/s13023-018-0926-z

Published Online: 2018-11-15

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pontes, Caridad https://orcid.org/0000-0002-3274-6048
Fontanet, Juan Manuel

Vives, Roser

Sancho, Aranzazu

Gómez-Valent, Mònica

Ríos, José

Morros, Rosa

Martinalbo, Jorge

Posch, Martin

Koch, Armin

Roes, Kit

Oude Rengerink, Katrien

Torrent-Farnell, Josep

Torres, Ferran
License Information

Text and Data Mining valid from 2018-11-15
More Information

Article History

Received: 14 June 2018

Accepted: 4 October 2018

First Online: 15 November 2018

Ethics approval and consent to participate

: Not applicable. No Ethics approval was required since no data on animal or human data or tissue was used for this project.

: Not Applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.